Auris Medical Holding AG (EARS) - Financial and Strategic SWOT Analysis Review

  • ID: 4284922
  • SWOT Analysis
  • 42 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • Aevis Victoria SA
  • Jungfraubahn Holding AG
  • Otonomy Inc
  • Sound Pharmaceuticals Inc
  • Strekin AG
  • MORE
Auris Medical Holding AG (EARS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Auris Medical Holding AG (Auris Medical) is a clinical-stage biopharmaceutical company that develops therapeutics to address unmet medical needs in the area of otolaryngology. The company’s pipeline encompasses investigational candidates targeted at the treatment of acute inner ear tinnitus, post-acute inner ear tinnitus, tinnitus, sudden loss of hearing, and Meniere’s disease (Vertigo). Auris Medical also carries out research to advance various early-stage development projects in the area of rhinology. It works in collaboration with various research and development institutions and pharmaceutical and biotechnology companies. Auris Medical is headquartered in Zug, Switzerland.

Auris Medical Holding AG Key Recent Developments

Aug 10,2017: Auris Medical Provides Business Update and Reports Second Quarter 2017 Financial Results
May 31,2017: Auris Medical to Host Key Opinion Leader Event Focused on Clinical-Stage Pipeline on June 16 in New York City
May 11,2017: Auris Medical Provides Business Update and Reports First Quarter 2017 Financial Results
Mar 14,2017: Auris Medical Provides Business Update and Reports Full Year 2016 Financial Results
Nov 10,2016: Auris Medical Provides Business Update and Reports Third Quarter 2016 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
*Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Aevis Victoria SA
  • Jungfraubahn Holding AG
  • Otonomy Inc
  • Sound Pharmaceuticals Inc
  • Strekin AG
  • MORE
Section 1 - About the Company
Auris Medical Holding AG - Key Facts
Auris Medical Holding AG - Key Employees
Auris Medical Holding AG - Key Employee Biographies
Auris Medical Holding AG - Major Products and Services
Auris Medical Holding AG - History
Auris Medical Holding AG - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis
Auris Medical Holding AG - Business Description
Auris Medical Holding AG - SWOT Analysis
SWOT Analysis - Overview
Auris Medical Holding AG - Strengths
Auris Medical Holding AG - Weaknesses
Auris Medical Holding AG - Opportunities
Auris Medical Holding AG - Threats
Auris Medical Holding AG - Key Competitors

Section 3 - Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Company’s Lifesciences Financial Deals and Alliances
Auris Medical Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Auris Medical Holding AG, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Auris Medical Holding AG, Recent Deals Summary

Section 5 - Company’s Recent Developments
Aug 10, 2017: Auris Medical Provides Business Update and Reports Second Quarter 2017 Financial Results
May 31, 2017: Auris Medical to Host Key Opinion Leader Event Focused on Clinical-Stage Pipeline on June 16 in New York City
May 11, 2017: Auris Medical Provides Business Update and Reports First Quarter 2017 Financial Results
Mar 14, 2017: Auris Medical Provides Business Update and Reports Full Year 2016 Financial Results
Nov 10, 2016: Auris Medical Provides Business Update and Reports Third Quarter 2016 Financial Results
Aug 18, 2016: Auris Medical Provides Business Update and Reports Second Quarter 2016 Financial Results
May 11, 2016: Auris Medical Provides Business Update and Reports First Quarter 2016 Financial Results
Mar 14, 2016: Auris Medical Provides Business Update and Reports Fourth Quarter and Full Year 2015 Financial Results

Section 6 - Appendix
Methodology
Ratio Definitions
About
Contact
Disclaimer

List of Tables
Auris Medical Holding AG, Key Facts
Auris Medical Holding AG, Key Employees
Auris Medical Holding AG, Key Employee Biographies
Auris Medical Holding AG, Major Products and Services
Auris Medical Holding AG, History
Auris Medical Holding AG, Subsidiaries
Auris Medical Holding AG, Key Competitors
Auris Medical Holding AG, Ratios based on current share price
Auris Medical Holding AG, Annual Ratios
Auris Medical Holding AG, Annual Ratios (Cont...1)
Auris Medical Holding AG, Interim Ratios
Auris Medical Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Auris Medical Holding AG, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Auris Medical Holding AG, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Auris Medical Holding AG, Performance Chart (2012 - 2016)
Auris Medical Holding AG, Ratio Charts
Auris Medical Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Auris Medical Holding AG, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Strekin AG
  • Sound Pharmaceuticals Inc
  • Otonomy Inc
  • Nordmark Arzneimittel GmbH & Co KG
  • Jungfraubahn Holding AG
  • Hennig Arzneimittel GmbH & Co KG
  • Castle Creek Pharmaceuticals LLC
  • Aevis Victoria SA
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll